ArticleJournal of managed care & specialty pharmacy2016

Use of Oritavancin in Moderate-to-Severe ABSSSI Patients Requiring IV Antibiotics: A U.S. Payer Budget Impact Analysis.

Ivar S Jensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.